Nuvation Bio Inc. Unrealized Gain (Loss) on Securities
Nuvation Bio Inc. (NUVB) reported Unrealized Gain (Loss) on Securities of -$369.00 thousand for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Income Statement › Other Income
us-gaap:UnrealizedGainLossOnSecurities · last filed 2021-11-10
- Nuvation Bio Inc. unrealized gain (loss) on securities for the quarter ending 2021-09-30 was -$369.00K.
- Nuvation Bio Inc. unrealized gain (loss) on securities for the quarter ending 2021-06-30 was -$224.00K, a 124.06% decline year-over-year.
- Nuvation Bio Inc. unrealized gain (loss) on securities for the quarter ending 2021-03-31 was -$576.00K, a 170.33% decline year-over-year.
- Nuvation Bio Inc. unrealized gain (loss) on securities for the quarter ending 2020-09-30 was -$350.00K.
| Period end | Unrealized Gain (Loss) on Securities 3 month | Unrealized Gain (Loss) on Securities 6 month | Unrealized Gain (Loss) on Securities 9 month |
|---|---|---|---|
| 2021-09-30 | -$369.00K 10-Q · filed 2021-11-10 | -$593.00K derived: sum of 2 quarters · filed 2021-11-10 | -$1.17M 10-Q · filed 2021-11-10 |
| 2021-06-30 | -$224.00K 10-Q · filed 2021-08-12 | -$800.00K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | -$576.00K 10-Q · filed 2021-05-17 | ||
| 2020-09-30 | -$350.00K 10-Q · filed 2021-11-10 | $581.00K derived: sum of 2 quarters · filed 2021-11-10 | $1.40M 10-Q · filed 2021-11-10 |
| 2020-06-30 | $931.00K 10-Q · filed 2021-08-12 | $1.75M 10-Q · filed 2021-08-12 | |
| 2020-03-31 | $819.00K 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B |